Blog: Valentia Lee Brotherton
Establishing Health-Based Exposure Limits for Active Pharmaceutical Ingredients
Are your manufacturing standards in line with the new EMA guideline? More…
Betting the Pharm: Determining Regulatory Expectations for Pharmacology Studies
Are you generating sufficient pharmacology data and presenting the data effectively for your preclinical drug development program? More…
Risky Business: Toxicological Risk Assessments to Support Product Safety
Extractables, leachables, impurities, degradants, contaminants – what else can go wrong? More…